Powered By Peps
Pharmaceutical Grade Research Lab
Reta-30 Pen Cartridge Product Reference / 01
Edition 2026
Reta-30 · Pre-filled · Argon-sealed

Retatrutide,
done properly.

Most research-grade reta vials go cloudy, lose potency, or arrive contaminated. Ours doesn't — because the formulation, the bacteriostatic water, and the cartridge were all engineered together. Here's what makes the difference, and how to use the cart from first dose to last.

01 ——

Why our retatrutide is better

Retatrutide is a lipidated peptide — a fatty acid tail bolted onto the protein backbone. That tail is what research associates with its long half-life, but it is also why most research-grade product fails. The fatty tail is described as wanting to stick to glass walls, associate with other molecules, and drop out of solution the moment pH drifts off-target.

We formulated around every one of those failure modes. Ours is not powder in a vial — it is a complete formulation with a buffer system, a chelator and a heavy lyoprotectant matrix baked directly into the lyophilised cake, so every stabilising excipient activates in the same instant the peptide does.

The result: clear solution on contact, stable for the life of the cartridge. No cloudiness. No chunks. No "wait an hour and swirl harder."

3 mL pen cartridge with lyophilised Retatrutide puck, argon-filled headspace
Structural
Lyoprotectant matrix
A glass-forming sugar that physically wraps each molecule during freeze-drying, standing in for the water shell that normally holds the protein together. Research describes this class of excipient as preventing crystallisation and denaturation in the cake. It is routinely omitted from grey-market product.
Stability
Buffered to target
A buffer system holds the solution inside the pH window the commercial GLP-1 literature specifies. Buffering means the pH actively resists drift across weeks of cartridge use rather than simply starting in the right place.
Formulation
pH balanced on contact
Separate from buffering: our bacteriostatic water and the cake's buffer system are matched so the reconstituted solution lands on target immediately. No adjustment, no drift, correct pH from the first second.
Protective
Anti-metals chelator
Locks up trace metal ions that the literature describes as catalysing peptide oxidation. Methionine residues are reported to degrade rapidly without this protection.
02 ——

The bacteriostatic water is engineered too

Every Reta-30 ships with a matched bacteriostatic water vial, and it is not a commodity diluent. Its starting pH is chosen so the cake's buffer system lands the reconstituted solution on target, and it is argon-sealed on the same line as the cartridge — because a perfect cartridge reconstituted with oxygenated water is not a protected product.

Why our bacteriostatic water is different →
03 ——

Why pen cartridges are better

A traditional vial sits there with the same headspace volume forever — every dose you pull, room air gets drawn back through the needle to replace what you took out. By the end of the vial, your last dose is sharing space with weeks of accumulated bacteria, oxygen, and dust nuclei. This is the single biggest reason reconstituted peptides degrade.

A pen cartridge works the opposite way. As the plunger advances with each dose, the air space shrinks instead of growing. By your last dose, there's almost no headspace at all — and what little exists has been steadily compressed and pushed out, not exchanged with the room.

Combine that mechanical advantage with how you reconstitute the cart in the first place — argon vents out, BAC water pushes in, never room air — and you get a sealed system from end to end. Bacteria physically cannot enter against the outward gas flow during reconstitution, and once sealed, the plunger compression keeps it that way.

Reta-30 pen cartridges showing the lyophilised peptide cake inside
Stability over time — the math that matters

Why ours is still working when theirs is gone.

Reta-30 — argon-sealed, buffered, stabilised
Same peptide reconstituted with Hospira BAC, no excipients
Chinese peptide vial, no buffer, no surfactant, room air
100% 80% 60% 40% 20% 0% PEPTIDE POTENCY D0 7 14 21 28 42 60 DAYS POST RECONSTITUTION 90% threshold 92% 25% 4% CLOUDS · DAY 5–7
Reta-30 · Day 60
92% potency
Still above the 90% pharma threshold two months after reconstitution. Argon seal + trehalose-wrapped cake + pH buffered & balanced + EDTA all working at once.
Hospira BAC · Day 60
25% potency
Same peptide with quality BAC water but no excipients in the cake. Slow oxidation + pH drift + glass adsorption all eat away at potency.
Chinese vial · Day 60
4% potency
Cloudy within a week from aggregation. Most of the peptide is stuck to the glass or precipitated out by month two. Essentially gone.
Reference curves based on observed stability data for lipidated GLP-1 peptides under varying excipient and storage conditions. Individual results may vary. Both comparison curves assume refrigerated 36–46°F storage — at room temperature, declines are 2–3× steeper.
04 ——

Reconstitution — your BAC goes into the cart

Each Reta-30 ships with a matched 1.8 mL bacteriostatic water vial. You transfer all of that BAC into the pen cartridge. The cart then dispenses against a 1.6mL working volume — the extra 0.2mL fills the dead space inside the pen mechanism so every dialed unit lands in the tissue, not lost in the device.

1
Wipe both septums
IPA swab on the BAC vial top and the cart septum. Let flash-dry.
2
Draw all 1.8mL of BAC
2mL syringe with fill needle (included in your kit). Pull all 1.8mL — premeasured, get every drop.
3
Insert vent needle into cart
30G or 32G pen needle through the cart septum. Argon flows out as BAC goes in.
Drawing 1.8mL of BAC water from the vial with a 2mL syringe and fill needle
4
Inject the BAC slowly
Down the inside wall of the cart, not directly onto the peptide. About 10 seconds.
5
Remove both needles, swirl gently
Roll between palms. Do not shake. Solution should clear within 60 seconds.
6
Load into pen and prime
Seat the cart, attach a fresh pen needle. Since we know exactly 1.8mL went in, you can safely dial a full 60 units for the first push to clear most of the air fast. After that, slow down — push 2 units at a time, needle-up, until you see a clear, steady stream shoot from the tip. That's your prime confirmation.
Insert vent needle into cart
05 ——

Pushing the air out — first prime & every dose

After reconstitution, a small pocket of argon mixed with a bit of dissolved gas will sit at the top of the cart. You want to push as much of it as possible out before your first dose. This shrinks the headspace for the rest of the cart's life — less air to absorb into solution, less surface area for the peptide to lose to oxidation over weeks of use.

The good news: priming the pen handles this automatically. Each prime push moves the plunger forward, compresses the gas pocket, and vents it through the needle. Once it's out, it can never get back in.

  1. Hold the pen needle-up so any gas pocket migrates to the top, near the needle.
  2. First push: dial a full 60 units and depress fully. Because we know exactly 1.8mL of BAC went into the cart, a 60-unit push is safe and will clear most of the headspace gas in one shot.
  3. After that, slow down. Dial 2 units at a time, push fully, and watch the needle tip. You'll see nothing at first — that's normal, you're still pushing gas out.
  4. Keep going 2 units at a time until a clear, steady stream of fluid shoots out of the tip. That stream is your confirmation — fluid is at the needle, gas is gone.
  5. Cart is purged. Dial your dose and inject.
  6. Every subsequent dose, do a quick 2-unit prime needle-up before dialing your real number. Confirms the line is clean, keeps the cart sharp through the last dose.
Load into pen and prime
06 ——

Dosage — Reta-30 titration

Phase Weeks Weekly dose Pen units Volume
Initiation 1-4 2mg/week 11 0.11 mL
First Escalation 5-8 4mg/week 21 0.21 mL
Second Escalation 9-12 8mg/week 43 0.43 mL
Maintenance 13-48 12mg/week 64 0.64 mL
Initiation Starting dose. Gradual titration critical -- direct 8mg start nearly doubled GI side effects in trials.
First Escalation Mid-range dose. Phase 2 showed -17.1% mean weight loss at 48 weeks at this dose level.
Second Escalation High therapeutic dose. Phase 2 showed -22.8% mean weight loss at 48 weeks.
Maintenance Maximum tested dose. Phase 2 showed -24.2% mean weight loss at 48 weeks. Most potent weight loss observed.
Reta-30 = 30 mg labelled / 32–35 mg actual in 1.6 mL working volume · ~18.75 mg/mL · 1 unit = 0.01 mL · weekly SubQ
Why over-filled?  Every Reta-30 cart contains 32–35 mg labelled as 30 mg — and the matched bacteriostatic water vial holds 1.8 mL instead of 1.6 mL. The extra peptide compensates for any minor loss during reconstitution, and the extra 0.2mL of BAC fills the pen's internal dead space. When you dose against the 1.6 mL working volume, you get the full clinical milligram you dialed — not a quietly short dose.
≤32°F
Powder · Freezer
36–46°F
Liquid · Refrigerator
Dark
Light Protected
60d+
After Reconstitution

© 2026 Powered By Peps. All rights reserved.

PROD